Evidence map›Paper›PMID 33010259›Full record

ArticleThe Journal of infection2021

Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France.

Chloé Dimeglio, Fabrice Herin, Marcel Miedougé, Jean-Pierre Cambus, Florence Abravanel, Jean-Michel Mansuy, Jean-Marc Soulat, Jacques Izopet

Abstract readLetterComment
In one paragraph

Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Chloé DimeglioVirology Laboratory, CHU Toulouse, Hôpital Purpan, 330 av de Grande Bretagne, 31300 France; UMR Inserm, U1043, UMR CNRS, U5282, Centre de Physiopathologie de Toulouse Purpan (CPTP), Toulouse 31300, France. Electronic address: dimeglio.c@chu-toulouse.fr.
Fabrice HerinOccupational Diseases Department, Toulouse-Purpan University Hospital, Toulouse 31000, France; Epidemiology, Health Economics and Public Health, UMR1027 INSERM, Toulouse, France.
Marcel MiedougéVirology Laboratory, CHU Toulouse, Hôpital Purpan, 330 av de Grande Bretagne, 31300 France.
Jean-Pierre CambusCHU Toulouse, Hematology Laboratory, Toulouse 31300, France.
Florence AbravanelVirology Laboratory, CHU Toulouse, Hôpital Purpan, 330 av de Grande Bretagne, 31300 France; UMR Inserm, U1043, UMR CNRS, U5282, Centre de Physiopathologie de Toulouse Purpan (CPTP), Toulouse 31300, France.
Jean-Michel MansuyVirology Laboratory, CHU Toulouse, Hôpital Purpan, 330 av de Grande Bretagne, 31300 France.
Jean-Marc SoulatOccupational Diseases Department, Toulouse-Purpan University Hospital, Toulouse 31000, France; Epidemiology, Health Economics and Public Health, UMR1027 INSERM, Toulouse, France.
Jacques IzopetVirology Laboratory, CHU Toulouse, Hôpital Purpan, 330 av de Grande Bretagne, 31300 France; UMR Inserm, U1043, UMR CNRS, U5282, Centre de Physiopathologie de Toulouse Purpan (CPTP), Toulouse 31300, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2FranceHealth PersonnelHospitals, UniversityHumans

Identifiers

PMID33010259
PMCPMC7526656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.